GM safflower oil byproduct approved as livestock feed

Arcadia Biosciences Inc. said Tuesday it has won approval from the U.S. Food and Drug Administration to sell a byproduct of its genetically modified safflower product as livestock feed.

The approval opens up a potentially large market of cattle and poultry producers for the Davis-based food technology company. It also “improves the overall production economics of GLA safflower oil,” CEO Eric Rey said in a news release.

For years, the company has sold its genetically modified safflower oil as a human nutritional supplement. The company now can market a byproduct of that oil, safflower seed meal, to animal-feed manufacturers.

Related on the SLP

The science of seed oils: Healthy or harmful? Claims of nutritional superiority of organic milk, meat challenged by scientists

White House drafting executive order to control what OMB Director Vought claims are “woke” NIH science grants

What’s Trump’s ‘AI Force’? Administration rushes to announce ill-defined watchdog and czar amid criticism of its resistance to curb AI acceleration

Trump says he’ll require drugmakers to end multiple vaccine doses, reviving discredited autism claims

Arcadia’s safflower seeds are high in omega-6 fatty acid, which some believe have anti-inflammation properties, as well as benefits for skin health, weight management and women’s hormonal balance.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Arcadia wins FDA approval to sell oil byproduct, opening up big new market